🇺🇸 Diphtheria Antitoxin in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 7 reports (43.75%)
  2. Acute Kidney Injury — 1 report (6.25%)
  3. Coma — 1 report (6.25%)
  4. Condition Aggravated — 1 report (6.25%)
  5. Diphtheria — 1 report (6.25%)
  6. Hypotension — 1 report (6.25%)
  7. Metabolic Acidosis — 1 report (6.25%)
  8. Multiple Organ Dysfunction Syndrome — 1 report (6.25%)
  9. Myocarditis — 1 report (6.25%)
  10. Off Label Use — 1 report (6.25%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Diphtheria Antitoxin approved in United States?

Diphtheria Antitoxin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Diphtheria Antitoxin in United States?

PT Bio Farma is the originator. The local marketing authorisation holder may differ — check the official source linked above.